Continuous Soluble Ferric Pyrophosphate (SFP) Iron Delivery Via Dialysate in Hemodialysis Patients (CRUISE 2)
Public ClinicalTrials.gov record NCT01322347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-Controlled, Phase III Study of Dialysate Containing Soluble Ferric Pyrophosphate (SFP) in Chronic Kidney Disease Patients Receiving Hemodialysis: The Continuous Replacement Using Iron Soluble Equivalents (CRUISE 2) Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to confirm the safety and efficacy of Soluble Ferric Pyrophosphate (SFP) dialysate solution in maintaining iron delivery for erythropoiesis in anemic adult patients with chronic kidney disease (CKD) receiving hemodialysis. Efficacy will be measured primarily by the change from baseline in hemoglobin (Hgb).
Study identification
- NCT ID
- NCT01322347
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 294 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2011 (Type not available)
- Primary completion
- Jan 2014 (Actual)
- Completion
- Feb 2014 (Actual)
- Last update posted
- Apr 26, 2017
2011 – 2014
United States locations
- U.S. sites
- 38
- U.S. states
- 15
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator | Paragould | Arkansas | 72450 | — |
| Investigator | Pine Bluff | Arkansas | 71603 | — |
| Investigator | Alhambra | California | 91801 | — |
| Investigator | Beverly Hills | California | 90211 | — |
| Investigator | Glendale | California | 91204 | — |
| Investigator | La Mesa | California | 91942 | — |
| Investigator | Long Beach | California | 90807 | — |
| Investigator | Lynwood | California | 90262 | — |
| Investigator | Paramount | California | 90723 | — |
| Investigator | Whittier | California | 90603 | — |
| Investigator | Pembroke Pines | Florida | 33025 | — |
| Investigator | Augusta | Georgia | 30901 | — |
| Investigator | Macon | Georgia | 31217 | — |
| Investigator | Meridian | Idaho | 83642 | — |
| Investigator | Hines | Illinois | 60141 | — |
| Investigator | Rockville | Maryland | 20850 | — |
| Investigator | Detroit | Michigan | 48236 | — |
| Investigator | Pontiac | Michigan | 48341 | — |
| Investigator | Southfield | Michigan | 48034 | — |
| Investigator | Eatontown | New Jersey | 07724 | — |
| Investigator | Brooklyn | New York | 11212 | — |
| Investigator | Fresh Meadows | New York | 11365 | — |
| Investigator | Great Neck | New York | 11021 | — |
| Investigator | Orchard Park | New York | 14127 | — |
| Investigator | The Bronx | New York | 10461 | — |
| Investigator | Bethany | Oklahoma | 73008 | — |
| Investigator | Bethlehem | Pennsylvania | 18017 | — |
| Investigator | Philadelphia | Pennsylvania | 19106 | — |
| Investigator | Philadelphia | Pennsylvania | 19144 | — |
| Investigator | Nashville | Tennessee | 37205 | — |
| Investigator | Nashville | Tennessee | 37232 | — |
| Investigator | Arlington | Texas | 76015 | — |
| Investigator | Fort Worth | Texas | 76104 | — |
| Investigator | Fort Worth | Texas | 76105 | — |
| Investigator | Houston | Texas | 77004 | — |
| Investigator | Houston | Texas | 77099 | — |
| Investigator | San Antonio | Texas | 78229 | — |
| Investigator | Fairfax | Virginia | 22033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01322347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2017 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01322347 live on ClinicalTrials.gov.